Ed note: this article was first published in 2015, but the ad continues to run and readers continue to ask about it, so we’re re-posting this teaser solution for you today. What follows has not been meaningfully updated or revised since it was originally published on March 14, 2015, though some minor updates have been […]
Articles
- Most Relevant
- Most Recent
Lots of readers have asked about the latest “almost perfect stock” pitch from Louis Navellier for his Blue Chip Growth newsletter (currently $100 a year), so that’s the Thinkolator’s project for today: What is it? Here’s the tantalizing lead-in: “Imagine… a technology company whose product you don’t install, that reduces business costs by billions a […]
Lots and lots and lots of you have been asking me about the big “cancer presentation” that the Stansberry folks made last night, which apparently was a combination of Dr. David Eifrig’s medical advice and forecasting and Dave Lashmet’s hinting about his “medical breakthrough” stock… so let’s get to it. I did not watch or […]
I love Thanksgiving. I love that we all try to remember to slow down our lives a little bit, spend time with family and friends, and give thanks for the incredible blessings most of us enjoy (and often take for granted). But I also love naming our annual “Turkey” teaser stock. What is this? Well, […]
Marin Katusa has gotten a fair amount of attention in these parts over the past year or so, mostly because he was one of the first to get back on board and invest heavily in Northern Dynasty early in 2016, when the conventional wisdom was still 100% that the mine would never enter into permitting […]
Newsletter promoters LOVE dates — using a specific day in the calendar, preferably a day within the next month or two, gives a sense of urgency to an ad and makes you feel like you have to sign up RIGHT NOW to avoid missing out on the profits that can be made. And Agora is […]
[ed. note: Michael Jorrin, who I dubbed “Doc Gumshoe” years ago, is a longtime medical writer (not a doctor) who writes for us a couple times a month about health issues, marketing, and trends. He does not typically focus on specific investment opportunities, but has agreed to our trading restrictions… as with all of our […]
What have we learned about teaser ads over the past decade or so? A lot, I hope, but two lessons stand out: First, dates in teaser ads are often made up and don’t really represent meaningful “catalyst” events, they’re just a way to make you feel rushed and get you to pull out your credit […]
Check out link below on the Topic: Why Biotech is the Best Place for your Money in 2017http://invictusnews.com/2017/06/03/why-biotech-is-the-best-place-for-your-money-in-2017/?caid=rtjzao0w&cid=w3IUSULNIPK2L1V51GVUTS7A
Marijuana stocks have been falling, and yet James Altucher is pitching his Altucher’s Investment Network newsletter ($49/yr) with the promise that he’s found the only one of these stocks you’ll ever need… and it’s all because of “a massive state-of-the-art greenhouse… that’s about to revolutionize the marijuana market as we know it.” So what’s he […]
This ad is an odd one, to be sure… it is essentially identical to an ad that was circulated in the Spring of 2017 about this “magic metal”, with Matt Badiali at the time claiming that the metal was rising in price, was about to skyrocket and provide a chance at 3,000% returns, and be […]
[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He has agreed to our trading restrictions, chooses his own topics, and his words and opinions are his own. You can see all of his past articles and most recent comments on his Stock Gumshoe page.] On Monday, April 24, 2017, Dr. […]
Scott Chan is pretty new to the world of newsletter pitchmen, but he’s apparently been working for Investing Daily for a while as a technology analyst, and is now headlining his second ad for them (that I’ve seen, at least). The last one was pitching a stem cell immunotherapy biotech stock (which hasn’t worked so […]
This article originally ran on May 24, 2016, when we were in the midst of a run on virtual reality teaser pitches that had lasted for months. Apparently the ad is running again and this older article has been difficult for readers to track down, because we’re getting lots and lots of questions about it […]
MAKE YOUR PORTFOLIO GREAT AGAIN ! This thread is a continuation of several threads posted previously by the author on gold and silver and hard asset investments. I am still a believer in hard assets. I also believe we are entering a period of inflation with continued dollar devaluation, higher interest rates, and a sluggish […]
[Ed. Note: Dr. KSS writes about medicine and biotech stocks for our Irregulars. He chooses his own topics, and his words and opinions are his own. He has agreed to our trading restrictions. Visit his Stock Gumshoe page for more.] Bacteria are prokaryotes. Animal cells, fungi and plants are eukaryotes. Prokaryotes tend to be acellular and […]
[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He has agreed to our trading restrictions, and his words and opinions are his own. You can find his bio and his past articles on his Stock Gumshoe page.] “The universe (which others call the Library) is composed of an indefinite and […]
Time once again for an overheated pitch from our friend Louis Navellier… he’s been circulating ads for his Emerging Growth newsletter ($695/yr) that promote several of his favorite ideas for the year ahead, including a rehash of his lithium pick from a few months ago as well as this newer (to me, at least) “World’s […]
This teaser solution was originally posted on October 5, 2016 — the ad has circulated very heavily at various times in the past 18 months, routinely driving a lot of questions our way, so I took another look in May of 2017 when the ad was last updated. The ad still carries the May, 2017 […]
This week I’m seeing a new wave of questions about this Jim Rickards ad from Agora, and the ad itself has been (clumsily) updated a few times since we covered it back in November of 2017 (the last version with the “by March 19, 2019” deadline even suggested that Yellen was still President of the […]
The latest ads from Cabot’s Global Stocks Explorer caught my eye with a “bypass the coronavirus” pitch. Here’s how the ad starts: “Bypass the Coronavirus…with this hidden gem at the heart of ‘the biggest investment boom in history’ “Operating revenue increased over 70%. “Gross profit surged 122%. “Net income was up over 60%. “Total bookings […]
Have you ever heard the quote, “nothing tastes as good as thin feels?” Such sayings have been attributed to waif model Kate Moss, plenty of her anorexic fans, and dozens of others in the perfection industry (including Stephen Covey), and I’ll confess that the sentiment has never resonated with me even a little bit (as […]
Since Star Wars day just passed (May the Fourth Be With You!), I guess it’s time for a “Death Star” story — this one comes from an ad for The Wealth Warrior ($99/yr), which is Jason Simpkins’ security and defense-focused intro-level newsletter from the Outsider Club. And the headline, of course, sounds terrifying: “Beijing’s Death […]
Please indulge Doc Gumshoe while he presents his musings on what’s going on in general in the health-care arena, and in particular, which new drugs are getting the FDA blessing and why, as well as which ones are getting the short straw. My impressions and conclusions are in some cases only loosely based on […]
The headline that snagged my attention was this: ‘Thirty-five Thousand Americans Die of Antibiotic-Resistant Infections Each Year” This was based on the Centers for Disease Control’s Antibiotic Resistance Threats in the United States, 2019, which led off with the statement that more than 2.8 million antibiotic-resistant infections occur in the US every year, and more […]
Not a lot of buying and selling going on this week, as the market continues to seem to be reacting only to the “thumbs up” or “thumbs down” sentiment over a possible Chinese trade deal, but I did find one stock to buy… and caught up on a few others that have been catching my […]
Matt McCall’s out with another high-priced promo letter that promises the potential for huge gains — this time, by finding the stocks that he thinks will benefit from China’s massive increase in health care spending in the years to come. The ad is for his Early Stage Investor, and he claims to be making a […]
Today we’ve got a bit of a quickie for you, mostly just because the clues that were dropped were extremely limited… but it also happens to be a stock I’ve looked at before, so I thought it was worth taking a second look today. Paul Mampilly over the weekend was peddling his True Momentum service […]
What have we learned about teaser ads over the past decade or so? A lot, I hope, but two lessons stand out: First, dates in teaser ads are often made up and don’t really represent meaningful “catalyst” events, they’re just a way to make you feel rushed and get you to pull out your credit […]
Geothermal is back! Paul Mampilly is circulating his “Ocean of Energy Under all 50 States” pitch once more, so it’s time to take another look. His ad is almost exactly the same as it was when we first covered it in March, 2017, but I’m sure the story must have changed a bit along the […]
This week I’m seeing a new wave of questions about this Jim Rickards ad from Agora, and the ad itself has been (clumsily) updated a few times since we covered it back in November of 2017 (the last version with the “by March 19, 2019” deadline even suggested that Yellen was still President of the […]
Marijuana stocks have been falling, and yet James Altucher is pitching his Altucher’s Investment Network newsletter ($49/yr) with the promise that he’s found the only one of these stocks you’ll ever need… and it’s all because of “a massive state-of-the-art greenhouse… that’s about to revolutionize the marijuana market as we know it.” So what’s he […]
This ad is an odd one, to be sure… it is essentially identical to an ad that was circulated in the Spring of 2017 about this “magic metal”, with Matt Badiali at the time claiming that the metal was rising in price, was about to skyrocket and provide a chance at 3,000% returns, and be […]
I covered this teaser pitch from Marin Katusa as part of a Friday File for our Irregulars way back in February, and I’m getting buckets of questions about this “Forever Royalties” pitch again so I thought I should double check and update this — and share it with everyone, not just our paying members (yes, […]
We’ve had questions about this ad pitch from John Del Vecchio over the past few days, and our accounts received a few copies of the ad directly from various sources as well in the past week or so… so I thought we’d look into these “hidden stocks” for you today. But I also looked back […]
I’ve been seeing ads for the Motley Fool’s Stock Advisor Canada service recently that catch the eye… mostly because they promise what we all want, the ability to find that one stock that will turn your small investment into a life-changing fortune. They do this by starting with the story of “Forty-dollar Frank” …. “When […]
I’m a little sad not to be in Omaha this weekend for the Berkshire meeting, but I’ll be watching some of the Q&A tomorrow to see how Warren and Charlie are looking and try to get some little nuggets of wisdom from them. The biggest news lately from Berkshire Hathaway (BRK-B) is that they’re at […]
I got stuck in a writing quagmire today, so no new teaser solution for you — but we’ve got one from February that’s still relevant that we can share. It first appeared in a Friday File for our Irregulars on February 22, and I’ve continued to get questions about it over the past couple months. […]
I’ve been meaning to check in on one of the few mutual funds that I’ve written in detail about for you, so in the absence of any other big portfolio moves we’ll take a minute for that today. DoubleLine Shiller Enhanced CAPE (DSEEX) is a “better mousetrap” kind of fund, which should make us start […]
As we close in on the end of the first quarter, it’s time to release some more data — I just posted the 2019 teaser tracking spreadsheet for you, you can find it on the tracking page along with all our previous years and use it both to see what we’ve been covering so far […]
Recent Comments
I'll leave just a general review about what I know on several of Frank's newsletters. He has lower priced newsletters, and he has expensive newsletters. He always touts the huge…...
Bought SHOP at 69 in maybe 2017ish? Sold at ~1400 near the top. Thought it was too frothy at that point. Got lucky there. PLTR since 2020. Intend to hold…...
But would you have held it without selling any as it went up by ~500% or so twice, then got cut in half twice, before 2023? Stock Advisor first teased…...
RXRX they bought shares of as part of a collaboration a year ago, the other holdings are much older -- Nano-X is a remnant of a venture investment that NVDA…...
Doesn't seem there's been much logic to the nuclear power business since the early 1970s... but who knows, maybe that's gradually changing. We'll see if that sticks -- BWXT, for…...
It is a chunk of money but you can make that back and more with just one good pick. I've been following James since 2017. I brought ETH at $273…...
Hi Travis I am wondering when we are going to organize things differently on Gumshoe? Whoever is running your internal search obviously wants us to toggle through a number of…...
NVIDIA has owned a little slice of SoundHound since it was a venture investment a long time ago -- maybe 2017? Would have to check. There was a flurry of…...
gov't numbers are like gov't schools. SPR was a wreck when trump got elected and he was gung ho on making the US an energy giant, even hiring an exxon…...
That's a repeat of their long-running teaser pitch for Arista Networks (ANET) -- last covered here. Arista had a subpar run from 2017-2022 or so, but has really taken off…...
I can't speak for Michael, but as I understand it that news came out of a scientific paper released about some coronaviruses (out of pangolins, in this case) that were…...
I agree. Why does everyone seem to hang on his every word? Very effective marketing. But not very effective results. I subscribed back in 2017-2018. I lost money on most…...
Travis, Like many or your subscribers I believe, I subscribe to the basic level service of two or three stock services. One of them is Motley Fool's Stock Advisor (Canada).…...
I joined Palm Beach Confidential in 2017 after listening to one of Teeka's videos, and since then I've made a ton of money by following his recommendations, in particular bitcoin,…...
Similarly with my 2017 Subaru Forester. Mostly get around 30 MPG. Currently it has around 60,000 miles on the odometer and an expected life of 250,000 miles. It is a…...
That's a blast from the past, Brainchip was teased as an AI and crypto idea back in 2017. It was a startup then, almost pre-revenue, and it looks like they…...
Must just be one of his "special report" stocks, I guess -- Oxford sometimes does that with other names (Alex Green has been calling Hon Hai/Foxconn his "one stock retirement"…...
Thank you Travis for your very informative write up on Lymes. I believe most folks are unaware of the different types of bacteria that can come with that tick bite.…...
That was a super-hyped story a few years back, I recall -- I owned it for a while from 2015-2017 or so, mostly before the name change (it started out…...
Hi so let me help everyone here - for background I have been in the space since 2017 and crypto is my second life. I will admit that I am…...
I've owned bitcoin, ethereum and a number of other cryptos for six years (since May 2017.), and what I've learned is that bitcoin and ethereum are great investments, but investing…...
Does anyone know how Grayscale Bitcoin Trust fits into this world? I was interested in getting a “piece” of the action during the hoopla of the 2017 era and bought…...
Thanks to Teeka and Palm Beach Confidential, I bought my first bitcoin and Ethereum in May 2017 (and I've added to my original stash). Since then, the price of bitcoin…...
Travis: Appreciate your effort and thoughtfulness of analysis of investing in P&C insurance sector. I find the maze of financial metrics of insurance stocks very complicated, not particularly helpful or…...
Does anyone want to go in on Teeka’s service? I’m familiar with staking but uncertain how to move forward with the process. I’ve been buying crypto since 2017 and a…...
Doc GS< no apologies necessary. Very readable, informative and appreciated. Perhaps a report on ALS research could be in th efuture. My first wife was diagnosed on June 1 ,2011…...
I left $2.58 worth of Cardano (ADA) in a Bittrex acct in 2017 when my wife brow-beat me into leaving Crypto and getting back to "reality". In 2021 I happened…...
Verily! I take all you have stated plus IP-6, AHCC, MCP and Fucoidan. Supposedly a dead man walking if I did not sign up for the Chemo and Hormones in…...
Nice summary. I purchased NVDA in 2017 or 2018 along with AMD and INTC because of the AI story. I had watched a documentary or an article about AI and…...
I bought $5000 of NVDA back in 2017 when you were chatting it up. (I know next to nothing about investing. Half of the terms you use in these newsletters…...
Yes. Used them decades ago while working, This was after Peter Lynch up to his retirement. Then Mario Gabelli for a few years. I liked Motley Fool and they were…...
Haven't looked yet, but I wouldn't be surprised if they're just rehashing their pitch for Knowles, which was running way back in 2017 as an "Alexa" play -- in case…...
https://secure.palmbeachgroup.com/?cid=MKT725485&eid=MKT726877&step=start&plcid=PLC174414&SNAID=SAC0014326223&email=deroseland@gmail.com&encryptedSnaid=j%205b3GySU%2FGSESCM37XHiiBbiJakTpqy26SwlMzxeqs%3D&emailjobid=5319828&emailname=20230324-LGD&assetId=AST292017&page=1...
Oh, and I forgot one little detail -- that quote from Techcrunch about Unity becoming a tech giant? That was from an article in 2017, five years ago, when it…...
Back in 2017 when he first started promoting his crypto service, he recommended XRP. I was close to its ATH around $3. I don't believe anything he promotes. He's long…...
Did you get CRO alert from Bryce at 50 cents? I did, my first rec from him. lol. I immediately knew there were no real gurus or special sauce in…...
TRAVIS, THANKS NICE STARTING A WEBSITE W/FACTUAL READS ALL SHOWING COMMON SENSE, WHICH IS ALL TOO UNCOMMON TODAY!!! PS TRAVIS: I FELT LED AFTER REACHING THIS CANCER REALM, MY SECOND…...
I am desperate for information from Simply Natural. I do have title to my one hectare purchased in 2017 for avocado plantings. Although better communication with the company has been…...
I have made 550% from Trade Desk. I first bought @ 6.30 in Nov 2017, and I bought more right after that. I also bought more in Jan 2020. My…...
Spoken like a true disciple of the ignorant, but entertaining nevertheless. There have been times when the Earth was hotter, colder and the same as it is now. The worst…...
My general rule is that if I need the money in the next five years, it doesn't belong in stocks. I see plenty to worry about as well, but I…...
Good riddance, honestly. I’m a lifetime member to PM’s service since 2017. I’m embarrassed to say I drank the koolaid even though his numbers provided in his newsletters were more…...
I know alot of people hate on Teeka but if you got his research pre 2017 BTC spike you easily made your money back and substantially more. I didn't get…...
There is no right or wrong here, there are different perspectives, and people buying for different reasons. If the market focuses more on valuation and less on growth, Intel will…...
I still check the board every week or so. Thanks to everyone still here contributing. I think hibernation is a good word for this. It has been brutal. For me…...
A more complete understanding shows that evil has been committed under every banner imaginable, whether religious, political, or otherwise. The trifecta of Mao, Stalin, and Hitler alone are thought to…...
Hi All, Thanks for having this thread! I was teetering on the $50 offer but decided to see if I could find some info first... Thankfully I found this thread...…...
Oh, so sorry for the delay, I've been slammed at work lately! I don't see anything for 4/8. The last sell order I see was from 3/30 to sell WAVES…...
ChargePoint Holdings (CHPT) is an American EV infrastructure company at the forefront of the electricity revolution. It built the largest network of EV charging stations in North America and Europe.…...
I've speculated on Ginkgo options, haven't yet looked into the company beyond the article I wrote last week or read Scorpion's report. The short report may well have merit, we…...